Publications by authors named "Steven Xanthoudakis"

11Publications

Correlating the fractional inhibition of caspase-3 in NT2 cells with apoptotic markers using an active-caspase-3 enzyme-linked immunosorbent assay.

Anal Biochem 2006 Mar 21;350(1):32-40. Epub 2005 Dec 21.

Department of Biochemistry and Molecular Biology/Medicinal Chemistry, Merck Frosst Centre for Therapeutic Research, Kirkland, Que., Canada.

View Article and Find Full Text PDF
March 2006

Gob-5 is not essential for mucus overproduction in preclinical murine models of allergic asthma.

Am J Respir Cell Mol Biol 2005 Sep 9;33(3):303-14. Epub 2005 Jun 9.

Department of Biochemistry and Molecular Biology, Merck Centre for Therapeutic Research, P.O. Box 1005, Pointe-Claire-Dorval, PQ, H9R 4P8 Canada.

View Article and Find Full Text PDF
September 2005

Solid phase synthesis of selective caspase-3 peptide inhibitors.

Bioorg Med Chem 2004 Mar;12(5):845-51

Merck Frosst Centre for Therapeutic Research, Merck Frosst Canada & Co. PO Box 1005, Pointe-Claire-Dorval, Québec, Canada H9R 4P8.

View Article and Find Full Text PDF
March 2004

NRAGE, a p75 neurotrophin receptor-interacting protein, induces caspase activation and cell death through a JNK-dependent mitochondrial pathway.

J Biol Chem 2002 Dec 9;277(50):48043-50. Epub 2002 Oct 9.

Centre for Neuronal Survival, Montreal Neurological Institute, McGill University, 3801 University Avenue, Montreal, Quebec H3A 2B4, Canada.

View Article and Find Full Text PDF
December 2002